Streetbeat News

Price Targets

JAZZ

RBC Capital analyst Gregory Renza has maintained an 'Outperform' rating on Jazz Pharmaceuticals (NASDAQ:JAZZ), but lowered the price target from $200 to $191.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:56 pm

JAMF

RBC Capital analyst Matthew Hedberg maintains an Outperform rating on Jamf Holding (NASDAQ:JAMF) but lowers the price target from $24 to $22.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:54 pm

JKHY

RBC Capital analyst Daniel Perlin has maintained a 'Sector Perform' rating on Jack Henry & Associates (NASDAQ:JKHY) and lowered the price target from $181 to $161.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:53 pm

BIIB

Biogen Inc (NASDAQ:BIIB) reported better-than-expected Q3 earnings with sales of $2.53 billion, beating the consensus of $2.39 billion. However, the company revised its FY23 revenues to decline in a low-single-digit percentage versus FY22. Following the earnings announcement, Wells Fargo and RBC Capital increased their price targets on Biogen, while Wedbush cut its price target.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 6:49 pm

HUBS

RBC Capital analyst Rishi Jaluria has reiterated an Outperform rating on HubSpot (NYSE:HUBS) and maintained a price target of $625.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:43 pm

FLT

RBC Capital analyst Daniel Perlin has maintained a 'Sector Perform' rating on Fleetcor Technologies (NYSE:FLT) but lowered the price target from $277 to $270.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:42 pm

RAMP

LiveRamp Holdings, Inc. (NYSE:RAMP) reported better-than-expected Q2 results and issued strong Q3 guidance. The company's Q2 earnings were 43 cents per share, beating market estimates of 24 cents per share. Q2 sales were $160 million, exceeding expectations of $152.26 million. LiveRamp anticipates Q3 revenue of $165 million, compared to estimates of $163.11 million. Following the earnings announcement, analysts from Morgan Stanley, Susquehanna, and Benchmark increased their price targets on LiveRamp.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 6:41 pm

FICO

RBC Capital analyst Ashish Sabadra has reiterated a 'Sector Perform' rating on Fair Isaac (NYSE:FICO) and maintained a price target of $875.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:40 pm

NVDA

Bernstein analyst Stacy Rasgon has reiterated an 'Outperform' rating on NVIDIA (NASDAQ:NVDA) and maintained a price target of $675.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:38 pm

ENV

RBC Capital analyst Daniel Perlin maintains a 'Sector Perform' rating on Envestnet (NYSE:ENV) and lowers the price target from $67 to $47.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 6:36 pm